Compare BRID & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRID | ZTEK |
|---|---|---|
| Founded | 1932 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Major Chemicals |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 78.2M |
| IPO Year | 1995 | 2022 |
| Metric | BRID | ZTEK |
|---|---|---|
| Price | $7.48 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.6K | ★ 67.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $174,257,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $7.24 | $0.55 |
| 52 Week High | $10.77 | $1.84 |
| Indicator | BRID | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 43.96 | 35.60 |
| Support Level | $7.43 | $0.55 |
| Resistance Level | $7.73 | $0.69 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 10.68 | 14.89 |
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.